PDB Short entry for 1NQ2 HEADER HORMONE/GROWTH FACTOR RECEPTOR 21-JAN-03 1NQ2 TITLE TWO RTH MUTANTS WITH IMPAIRED HORMONE BINDING COMPND MOL_ID: 1; COMPND 2 MOLECULE: THYROID HORMONE RECEPTOR BETA-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: THRB OR NR1A2 OR ERBA2 OR THR1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 DE3 PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS ALPHA HELICAL, LIGAND BINDING DOMAIN, HORMONE-GROWTH FACTOR RECEPTOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR B.R.HUBER,B.SANDLER,B.L.WEST,S.T.CUNHA-LIMA,H.T.NGUYEN,J.W.APRILETTI, AUTHOR 2 J.D.BAXTER,R.J.FLETTERICK REVDAT 6 03-APR-24 1NQ2 1 REMARK REVDAT 5 14-FEB-24 1NQ2 1 REMARK SEQADV LINK REVDAT 4 16-NOV-11 1NQ2 1 HETATM REVDAT 3 13-JUL-11 1NQ2 1 VERSN REVDAT 2 24-FEB-09 1NQ2 1 VERSN REVDAT 1 15-APR-03 1NQ2 0 JRNL AUTH B.R.HUBER,B.SANDLER,B.L.WEST,S.T.CUNHA-LIMA,H.T.NGUYEN, JRNL AUTH 2 J.W.APRILETTI,J.D.BAXTER,R.J.FLETTERICK JRNL TITL TWO RESISTANCE TO THYROID HORMONE MUTANTS WITH IMPAIRED JRNL TITL 2 HORMONE BINDING JRNL REF MOL.ENDOCRINOL. V. 17 643 2003 JRNL REFN ISSN 0888-8809 JRNL PMID 12554782 JRNL DOI 10.1210/ME.2002-0095 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 9.5 REMARK 3 NUMBER OF REFLECTIONS : 13742 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1396 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1938 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 219 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 40.79 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 6.88 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1NQ2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-FEB-03. REMARK 100 THE DEPOSITION ID IS D_1000018097. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 277 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL7-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.08 REMARK 200 MONOCHROMATOR : CYCLINDRICALLY BENT TRIANGULAR REMARK 200 SI ASYMMETRIC CUT, HORIZONTAL REMARK 200 FOCUS MONOCHROMATOR REMARK 200 OPTICS : PT-COATED, FUSED SILICA, REMARK 200 VERTICAL FOCUSMIRROR, REMARK 200 CYCLINDRICALLY BENT TRIANGULAR REMARK 200 SI ASYMMETRIC CUT, HORIZONTAL REMARK 200 FOCUS MONOCHROMATOR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 96581 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 25.12 REMARK 200 R MERGE (I) : 0.06500 REMARK 200 R SYM (I) : 0.05200 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 105.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: THYROID HORMONE RECEPTOR BETA WITH TRIAC BOUND REMARK 200 (UNPUBLISHED) REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 700 MM SODIUM ACETATE, 200MM SODIUM REMARK 280 SUCCINATE 100MM SODIUM CACODYLATE, PH 7.2, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.80000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 87.60000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 87.60000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 43.80000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22490 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -70.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 103.43100 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 59.71592 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 43.80000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 NA NA A 700 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 254 REMARK 465 ILE A 255 REMARK 465 VAL A 256 REMARK 465 ASN A 257 REMARK 465 ALA A 258 REMARK 465 PRO A 259 REMARK 465 GLU A 260 REMARK 465 GLY A 261 REMARK 465 ASP A 461 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 217 CG CD OE1 OE2 REMARK 470 LYS A 223 CG CD CE NZ REMARK 470 GLU A 227 CG CD OE1 OE2 REMARK 470 LYS A 244 CG CD CE NZ REMARK 470 GLU A 248 CG CD OE1 OE2 REMARK 470 GLN A 252 CG CD OE1 NE2 REMARK 470 LYS A 263 CG CD CE NZ REMARK 470 HIS A 271 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 274 CG CD CE NZ REMARK 470 GLU A 324 CG CD OE1 OE2 REMARK 470 GLU A 333 CG CD OE1 OE2 REMARK 470 SER A 359 OG REMARK 470 GLU A 390 CG CD OE1 OE2 REMARK 470 LYS A 394 CG CD CE NZ REMARK 470 HIS A 413 CG ND1 CD2 CE1 NE2 REMARK 470 HIS A 416 CG ND1 CD2 CE1 NE2 REMARK 470 HIS A 441 CG ND1 CD2 CE1 NE2 REMARK 470 GLU A 445 CG CD OE1 OE2 REMARK 470 THR A 448 OG1 CG2 REMARK 470 GLU A 449 CG CD OE1 OE2 REMARK 470 GLU A 457 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 988 O HOH A 1015 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 201 24.68 -64.78 REMARK 500 ALA A 234 109.71 -35.88 REMARK 500 GLN A 235 -92.26 90.99 REMARK 500 SER A 237 -68.05 23.01 REMARK 500 LYS A 242 48.42 -102.99 REMARK 500 GLU A 248 17.58 -59.61 REMARK 500 GLU A 333 -68.01 -105.14 REMARK 500 CYS A 388 57.80 -93.79 REMARK 500 LYS A 411 70.92 54.93 REMARK 500 GLU A 445 -72.13 -123.04 REMARK 500 PRO A 452 129.46 -34.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ARS A 602 AS REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 388 SG REMARK 620 2 HOH A 952 O 84.5 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 700 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A 974 O REMARK 620 2 HOH A 978 O 71.6 REMARK 620 N 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 700 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4HY A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARS A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARS A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARS A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARS A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARS A 604 DBREF 1NQ2 A 202 461 UNP P10828 THB1_HUMAN 202 461 SEQADV 1NQ2 ALA A 198 UNP P10828 CLONING ARTIFACT SEQADV 1NQ2 SER A 199 UNP P10828 CLONING ARTIFACT SEQADV 1NQ2 ALA A 200 UNP P10828 CLONING ARTIFACT SEQADV 1NQ2 ALA A 201 UNP P10828 CLONING ARTIFACT SEQADV 1NQ2 THR A 317 UNP P10828 ALA 317 VARIANT SEQADV 1NQ2 GLU A 322 UNP P10828 ASP 322 CONFLICT SEQRES 1 A 264 ALA SER ALA ALA GLU GLU LEU GLN LYS SER ILE GLY HIS SEQRES 2 A 264 LYS PRO GLU PRO THR ASP GLU GLU TRP GLU LEU ILE LYS SEQRES 3 A 264 THR VAL THR GLU ALA HIS VAL ALA THR ASN ALA GLN GLY SEQRES 4 A 264 SER HIS TRP LYS GLN LYS ARG LYS PHE LEU PRO GLU ASP SEQRES 5 A 264 ILE GLY GLN ALA PRO ILE VAL ASN ALA PRO GLU GLY GLY SEQRES 6 A 264 LYS VAL ASP LEU GLU ALA PHE SER HIS PHE THR LYS ILE SEQRES 7 A 264 ILE THR PRO ALA ILE THR ARG VAL VAL ASP PHE ALA LYS SEQRES 8 A 264 LYS LEU PRO MET PHE CYS GLU LEU PRO CYS GLU ASP GLN SEQRES 9 A 264 ILE ILE LEU LEU LYS GLY CYS CYS MET GLU ILE MET SER SEQRES 10 A 264 LEU ARG THR ALA VAL ARG TYR GLU PRO GLU SER GLU THR SEQRES 11 A 264 LEU THR LEU ASN GLY GLU MET ALA VAL THR ARG GLY GLN SEQRES 12 A 264 LEU LYS ASN GLY GLY LEU GLY VAL VAL SER ASP ALA ILE SEQRES 13 A 264 PHE ASP LEU GLY MET SER LEU SER SER PHE ASN LEU ASP SEQRES 14 A 264 ASP THR GLU VAL ALA LEU LEU GLN ALA VAL LEU LEU MET SEQRES 15 A 264 SER SER ASP ARG PRO GLY LEU ALA CYS VAL GLU ARG ILE SEQRES 16 A 264 GLU LYS TYR GLN ASP SER PHE LEU LEU ALA PHE GLU HIS SEQRES 17 A 264 TYR ILE ASN TYR ARG LYS HIS HIS VAL THR HIS PHE TRP SEQRES 18 A 264 PRO LYS LEU LEU MET LYS VAL THR ASP LEU ARG MET ILE SEQRES 19 A 264 GLY ALA CYS HIS ALA SER ARG PHE LEU HIS MET LYS VAL SEQRES 20 A 264 GLU CYS PRO THR GLU LEU PHE PRO PRO LEU PHE LEU GLU SEQRES 21 A 264 VAL PHE GLU ASP HET NA A 700 1 HET 4HY A 500 21 HET ARS A 600 1 HET ARS A 601 1 HET ARS A 602 1 HET ARS A 603 1 HET ARS A 604 1 HETNAM NA SODIUM ION HETNAM 4HY [4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC HETNAM 2 4HY ACID HETNAM ARS ARSENIC FORMUL 2 NA NA 1+ FORMUL 3 4HY C14 H9 I3 O4 FORMUL 4 ARS 5(AS) FORMUL 9 HOH *219(H2 O) HELIX 1 1 ALA A 201 ILE A 208 1 8 HELIX 2 2 THR A 215 ASN A 233 1 19 HELIX 3 3 ASP A 265 LYS A 274 1 10 HELIX 4 4 ILE A 275 LYS A 289 1 15 HELIX 5 5 LEU A 290 GLU A 295 1 6 HELIX 6 6 PRO A 297 VAL A 319 1 23 HELIX 7 7 THR A 337 GLY A 344 1 8 HELIX 8 8 GLY A 347 SER A 361 1 15 HELIX 9 9 SER A 362 ASN A 364 5 3 HELIX 10 10 ASP A 366 MET A 379 1 14 HELIX 11 11 CYS A 388 LYS A 411 1 24 HELIX 12 12 HIS A 416 LYS A 443 1 28 HELIX 13 13 PRO A 447 PHE A 451 5 5 HELIX 14 14 PRO A 452 PHE A 459 1 8 SHEET 1 A 3 LYS A 244 PHE A 245 0 SHEET 2 A 3 MET A 334 VAL A 336 1 O ALA A 335 N LYS A 244 SHEET 3 A 3 LEU A 328 LEU A 330 -1 N LEU A 330 O MET A 334 LINK SG CYS A 294 AS ARS A 601 1555 1555 2.73 LINK SG CYS A 298 AS ARS A 600 1555 1555 2.90 LINK SG CYS A 388 AS ARS A 602 1555 1555 2.89 LINK SG CYS A 434 AS ARS A 603 1555 1555 2.83 LINK SG CYS A 434 AS ARS A 604 1555 1555 2.97 LINK AS ARS A 602 O HOH A 952 1555 1555 2.84 LINK NA NA A 700 O HOH A 974 1555 1555 2.81 LINK NA NA A 700 O HOH A 978 1555 1555 2.99 SITE 1 AC1 3 ASP A 351 HOH A 974 HOH A 978 SITE 1 AC2 11 PHE A 272 ALA A 279 ARG A 282 MET A 313 SITE 2 AC2 11 THR A 317 ASN A 331 LEU A 346 ILE A 353 SITE 3 AC2 11 HIS A 435 MET A 442 PHE A 455 SITE 1 AC3 1 CYS A 298 SITE 1 AC4 1 CYS A 294 SITE 1 AC5 3 CYS A 388 ARG A 391 HOH A 952 SITE 1 AC6 2 ASP A 427 CYS A 434 SITE 1 AC7 1 CYS A 434 CRYST1 68.954 68.954 131.400 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014502 0.008373 0.000000 0.00000 SCALE2 0.000000 0.016746 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007610 0.00000